Clinical SupplementPowered by HealixAI • HSA/FSA Eligible
Clinical Multi-Strain Probiotic
Delayed-release clinical probiotic with clinically studied Lactobacillus, Bifidobacterium, and Saccharomyces strains
Clinically Reviewed by HealixAI Board-Certified Physicians•Gastroenterology & Microbiome Formulary•HCPCS / Code: LMN-213D
HSA / FSA Eligible • Save ~30%
Enlarge1/2 ViewsEnlarge Studio View
Medical Dispensary
Clinical Multi-Strain Probiotic (50 Billion CFU)
Chart Indication: K58.9 (Irritable bowel syndrome without diarrhea)
Acid-resistant Lactobacillus, Bifidobacterium, and Saccharomyces strains dosed 2 hours apart from antibiotics to protect mucosal flora.
$41.00$54.00~$28.70 w/ HSA·FSA
In Stock • Direct Dispatch via Medical Dispensary
Compare stores:
Qualifying Health Goals (HSA/FSA)
- Irritable bowel syndrome without diarrhea
- Irritable bowel syndrome with diarrhea
- Constipation, unspecified
- Noninfective gastroenteritis and colitis, unspecified
Clinical Guidance & Safety
AGA Clinical Practice Guidelines on Probiotics — Acid-resistant Lactobacillus & Bifidobacterium strains for post-antibiotic & IBS gut restoration.
Want dosing & safety tailored to your lab results and medications?
Sync your health records or ask Healix Medical Intelligence by voice on this page.
